.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Researchers have identified that ATM deficiency pancreatic cancer significantly alters the tumor microenvironment (TME) through specific genetic pathways. This genotype-specific reprogramming enhances cancer aggressiveness by influencing bidirectional tumor-stroma interactions. Specifically, the loss of ATM serine/threonine kinase drives the differentiation of cancer-associated fibroblasts (CAFs) into a myofibroblastic phenotype (myCAF). This process occurs independently of the p53 status, highlighting a unique role for ATM in structural tumor dynamics.
The study demonstrates that ATM loss increases reactive oxygen species and enhances contractility signaling within the epithelium. Consequently, this leads to an elevated secretion of TGF-β1. This signaling molecule acts as a primary messenger that transforms the surrounding niche into a cancer-promoting environment. Moreover, the resulting myCAFs contribute directly to chemoresistance, making traditional treatments less effective for patients with this specific genetic profile.
Pharmacological inhibition of the TGF-β pathway shows significant clinical promise. In experimental models, blocking this signal reversed myCAF differentiation and sensitized tumors to chemotherapy. Therefore, dual targeting of both the intrinsic epithelial defects and the extrinsic stromal vulnerabilities represents a potent precision oncology strategy. These findings emphasize the importance of identifying the ATM status in patients to tailor more effective therapeutic interventions.
ATM loss increases TGF-β1 secretion, which reprograms fibroblasts into myofibroblasts, creating a niche that supports tumor growth and resists chemotherapy.
Yes, research indicates that TGF-β inhibition can reverse aggressive stromal changes and improve the efficacy of chemotherapy in ATM-deficient models.
Disclaimer: This content is for informational and educational purposes only and does not constitute medical advice. Always seek the advice of a qualified healthcare provider regarding any medical condition. Refer to the latest local and national guidelines for clinical practice.
References
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
New research shows ATM deficiency in pancreatic cancer triggers TGF-β signaling to create an aggressive niche, offering promising precision oncology targets...
5 months ago
Novel diimide and hydrazone scaffolds, particularly compound #C4, synergistically reactivate latent HIV-1 when combined with JQ1 or PKC activators. Demonstrating donor-matched proviral transcription ex vivo and non-canonical signaling, these findings advance shock and kill strategies toward reservoir eradication.
Today
A comparative cohort study evaluates vNOTES vs TLH hysterectomy for benign conditions, demonstrating shorter operative duration, faster return to daily activities, and equivalent female sexual function scores without increased dyspareunia.
Today
Review how tailored exercise programs benefit frail older patients with heart failure. Explore pathophysiological mechanisms, individualized training prescriptions, and strategies to overcome adherence barriers in clinical practice.
Yesterday
This comparative study evaluates posterior labral tears with and without glenohumeral instability, highlighting distinct demographic patterns, MRI underestimation in stable shoulders, and successful arthroscopic repair outcomes.
Yesterday
A clinical study demonstrates that early intervention with tocilizumab, either as monotherapy or bridged with corticosteroids, achieves significant proptosis reduction and resolves active inflammation in treatment-naive thyroid eye disease.
Today
